Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: A comparison of acute toxicity and quality of life

Radiotherapy and Oncology

Volumn 108, Issue 2, 2013, Pages 320-325

  Jain, Suneil ^a   Poon, Ian ^b   Soliman, Hany ^b   Keller, Brian ^b   Kim, Anthony ^b   Lochray, Fiona ^b   Yeung, Latifa ^c   Cheung, Patrick ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute toxicity; Lung cancer; Lung metastases; Quality of life; SABR; SBRT; Stereotactic

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DYSPNEA; ESOPHAGITIS; FATIGUE; FEMALE; FRACTURE; HEALTH CARE DELIVERY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TREATMENT DURATION; TUMOR VOLUME;

ACUTE TOXICITY; LUNG CANCER; LUNG METASTASES; QUALITY OF LIFE; SABR; SBRT; STEREOTACTIC;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RADIATION DOSAGE; RADIATION INJURIES; RADIOSURGERY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885388320     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.045     Document Type: Article

References (27)

1. S. Senthi, F.J. Lagerwaard, and C.J. Haasbeek Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
2. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
3. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 7 2007 S94 S100
4. S. Senthi, C.J. Haasbeek, B.J. Slotman, and S. Senan Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review Radiother Oncol 106 2013 276 282
5. K.M. Creach, J.D. Bradley, P. Mahasittiwat, and C.G. Robinson Stereotactic body radiation therapy in the treatment of multiple primary lung cancers Radiother Oncol 104 2012 4
6. Radiation therapy oncology group 0915. A randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Version date 8/19/2010. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails. aspx?study=0915.
7. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431
8. M.C. Stauder, O.K. Macdonald, and K.R. Olivier Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions Radiother Oncol 99 2011 166 171
9. K. Han, P. Cheung, and P.S. Basran A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors Radiother Oncol 95 2010 103 108
10. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 2003 365 376
11. B. Bergman, N.K. Aaronson, and S. Ahmedzai The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life Eur J Cancer 30 2005 635 642
12. D. Osoba, A. Bezjak, and M. Brundage Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the national cancer institute of Canada clinical trials group Eur J Cancer 41 2005 280 287
13. J. Bradley Radiographic response and clinical toxicity following SBRT for stage I lung cancer J Thorac Oncol 2 2007 S118 S124
14. A. Loblaw, P. Cheung, and L. D'Alimonte Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes Radiother Oncol 107 2013 153 158
15. S.Y. Song, W. Choi, and S.S. Shin Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus Lung Cancer 66 2009 89 93
16. Hiraoka, M, Nagata Y, Shibata H, et al. Results of a phase II study of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer by Japan Clinical Oncology Group (JCOG0403). Presented at the Chicago Multidisciplinary Symposium in Thoracic, Chicago, IL, December 9-11, 2010.
17. Radiation therapy oncology group 0813. Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. Version date 7/23/2012. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails. aspx?study=0813.
18. M. Baumann, T. Herrmann, and R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
19. M. Saunders, S. Dische, A. Barrett, A. Harvey, G. Griffiths, and M. Marmar Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial Radiother Oncol 52 1999 137 148
20. S. Dische, M. Saunders, and A. Barrett A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
21. S.M. Bentzen, J.Z. Skoczylas, and J. Bernier Quantitative clinical radiobiology of early and late lung reactions Int J Radiat Biol 764 2000 453 462
22. J. Cho, R. Kodym, S. Seliounine, J.A. Richardson, T.D. Solberg, and M.D. Story High dose-per-fraction irradiation of limited lung volumes using an image-guided, highly focused irradiator: simulating stereotactic body radiotherapy regimens in a small-animal model Int J Radiat Oncol Biol Phys 77 2010 895 902
23. A.W. Lee, W.M. Sze, and J.F. Fowler Caution on the use of altered fractionation for nasopharyngeal carcinoma Radiother Oncol 52 1999 207 211
24. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
25. F.J. Lagerwaard, N.K. Aaronson, and C.M. Gundy Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer J Thorac Oncol 7 2012 1148 1154
26. J. Widder, D. Postmus, and J.F. Ubbels Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer Int J Radiat Oncol Biol Phys 81 2011 e291 e297
27. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839